'Biosimilars' presentation slideshows

Publishers of Biosimilars Review & Report

SM. Health Communications, LLC. Publishers of Biosimilars Review & Report. SM. Health Communications, LLC. A full-service editorial services and consulting company, with special expertise in health care writing, editing, consulting, market research, and project management. Payer markets

93 views • 9 slides

Indonesia generated the highest revenue in the ASEAN biosimilars market in 2017 and is expected to remain dominant throughout the forecast period. Based on molecule type, the erythropoietin segment accounted for the second highest share in the ASEAN and China biosimilars market in 2017 and is expected to maintain this trend throughout the forecast period. Based on application, the blood disorders segment is estimated to rank second in terms of revenue in both, the ASEAN, and the China biosimilars market throughout the analysis period. The diabetes segment generated the highest CAGR from 2018 to 2025 in the ASEAN and China biosimilars market.

83 views • 8 slides

Indonesia generated the highest revenue in the ASEAN biosimilars market in 2017 and is expected to remain dominant throughout the forecast period. Based on molecule type, the erythropoietin segment accounted for the second highest share in the ASEAN and China biosimilars market in 2017 and is expected to maintain this trend throughout the forecast period. Based on application, the blood disorders segment is estimated to rank second in terms of revenue in both, the ASEAN, and the China biosimilars market throughout the analysis period. The diabetes segment generated the highest CAGR from 2018 to 2025 in the ASEAN and China biosimilars market.

85 views • 8 slides

Biosimilars Market Strategic Growth Insights 2030

Biosimilars are bio-medical products that are identical copies of an original pharmaceutical drug, which has been manufactured by a different manufacturing company. Biosimilars are manufactured once the patent of the original product expires. Unlike generic drugs, biosimilars exhibit high molecular complexity and are sensitive to alterations in the processes of manufacturing. These drugs are similar to reference products, in terms of purity, safety and potency.

83 views • 8 slides

Biosimilars Market is Expanding at a CAGR of 31.4%% from 2019-2030

Biosimilars are bio-medical products that are identical copies of an original pharmaceutical drug, which has been manufactured by a different manufacturing company. Biosimilars are manufactured once the patent of the original product expires. Unlike generic drugs, biosimilars exhibit high molecular complexity and are sensitive to alterations in the processes of manufacturing. These drugs are similar to reference products, in terms of purity, safety and potency.

84 views • 8 slides

Biosimilars Market - Global Industry Analysis and Forecast t

Biosimilars or follow-on biologics are biopharmaceutical drugs that are similar to approved biological drugs. Biosimilars are different from other generic drugs in terms of raw material and their manufacturing process. Generic drugs are composed of small molecules. However, biosimilars are composed of more complex molecules, such as human insulin and monoclonal antibodies. Many biosimilars are derived from plants, animals, bacteria, viruses and yeast. It is produced by recombinant DNA technology and controlled gene expression methods. Biosimilar drugs are used in prevention and treatment of various severe diseases such as cancer, diabetes, autoimmune diseases, heart attacks, rheumatoid arthritis, oncology, growth hormone deficiency, chronic kidney failure, hematological disease and infectious disease. Biosimilars offer less costly treatment than other biological drugs and synthetic drugs.

254 views • 7 slides

BIOSIMILARS Market- Size, Share, Trends, Forecast, Outlook

Big Market Research has announced a new Report Package "BIOSIMILARS Market- Types, End Users, Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/biosimilars-regulatory-framework-and-pipeline-analysis-market Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially. Enquire About This Report at: http://www.bigmarketresearch.com/report-enquiry/311220

220 views • 7 slides

Global Biosimilars Market

163 views • 7 slides

Know the Factors that Driving the Growth of Biosimilars Market

Biosimilars Market report provides a detailed analysis of drivers and factors that limit the market expansion. The report provides market forecast for the next eight years by considering the 2014 as the base year for evaluation

83 views • 7 slides

Global Biologics And Biosimilars Industry 2015 Deep Market R

313 views • 6 slides

Biologics And Biosimilars Industry 2015 - Market Size, Share, Growth & Opportunities

Global Biologics And Biosimilars Industry, report also presents product specification, manufacturing process, and product value etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.In the end, the report includes Biologics and Biosimilars new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. Read more details at: http://www.bigmarketresearch.com/global-biologics-and-biosimilars-industry-2015-deep-research-report-market

285 views • 6 slides

Biosimilars Market And its Growth prospect in the Near Future

On the basis of technology, the biosimilars market is categorized into five categories, such as monoclonal antibody (mAb), recombinant deoxyribonucleic acid (rDNA), bioassays, nuclear magnetic resonance (NMR), and electrophoresis. Biosimilars manufactured using mAb technology held the largest share, of 56%, in 2018. This technology is also expected to be the fastest growing category in the market, owing to large development of therapeutics with the help of this technology for various diseases such as cancer, immunological, and infectious diseases. Geographically, Europe held the largest share, of 47.7%, in the biosimilars market in 2018. This is attributed to flexible regulatory framework, growing geriatric population, and rising R&D investment by biopharmaceutical companies in the region. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/biosimilars-market

66 views • 6 slides

United States Biologics and Biosimilars Market Report 2016

VISIT HERE @ http://www.grandresearchstore.com/pharmaceuticals/united-states-biologics-and-biosimilars-market-report-2016 This Report provided by GrandResearchStore is about, Sales (consumption) of Biologics and Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Pfizer Roche Amgen AbbVie Sanofi Johnson & Johnson

161 views • 5 slides

Global Biosimilars Market Is Expected To Reach US$ 25.83 Bn By 2025

The Biosimilars  market was valued at US$ 3.52 Bn in 2016, and is expected to reach US$ 25.83 Bn by 2025, expanding at a CAGR of  23.1% from 2017 to 2025.

46 views • 4 slides

Biosimilars Market Growth, Size, Share and Top Trends 2019-2030

Market Industry Reports (MIR) has published a new report titled u201cBiosimilars Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019u20132030.u201d According to the report, the global Biosimilars market was estimated to be over US$ 4,500 Mn in 2018. It is anticipated to grow at a double digit CAGR from 2019 to 2030.

34 views • 3 slides

Biosimilars Market is anticipated to grow at a double digit CAGR from 2019 to 2030.

As indicated by the report, the worldwide Biosimilars market was evaluated to be over US$ 4,500 Mn in 2018. It is foreseen to develop at a double digit CAGR from 2019 to 2030.

40 views • 3 slides

Biosimilars Market Size, Share, Trends, Competitive Strategies, Analysis, Key Players & Forecast by 2030

According to the report, the global Biosimilars market was estimated to be over US$ 4,500 Mn in 2018. It is anticipated to grow at a double digit CAGR from 2019 to 2030.

37 views • 3 slides

Middle East and Africa Biosimilars Market Market: Industry Analysis & Opportunities-Market Data Forecast

rowing economies are observing comprehensive growth in biosimilars industry from demanding clinical needs of therapeutics

23 views • 2 slides

Biosimilars Market Valuable Growth Prospects and Forecasting till 2030

Get free sample@ https://www.marketindustryreports.com/pdf/67

26 views • 2 slides